Publication: Effects of 18-month Vildagliptin Treatment on Portal Vein Pressure and Hepatosteatosis
Loading...
Files
Date
2019-10-01T00:00:00Z
Authors
KARATOPRAK, CUMALİ
KISKAÇ, MUHARREM
ZORLU, MEHMET
ÇAKIRCA, MUSTAFA
Aydin, Sinem
Ozkan, Tuba
Journal Title
Journal ISSN
Volume Title
Publisher
Metrics
Abstract
Objective: Patients with type 2 diabetes have an increased tendency to develop hepatosteatosis. The effects of drugs used to treat diabetes on the liver, regardless of the disease, are unknown.The aim of this study was to investigate the effects of vildagliptin, a dipeptidyl peptidase-4 inhibitor, on the portal vein pressure and hepatosteatosis in patients with type 2 diabetes in the 18 months of follow-up.
Description
Keywords
Citation
KARATOPRAK C., Kilicarslan R., ÇAKIRCA M., Aydin S., Ozkan T., ZORLU M., KISKAÇ M., -Effects of 18-month Vildagliptin Treatment on Portal Vein Pressure and Hepatosteatosis-, BEZMIALEM SCIENCE, cilt.7, ss.317-321, 2019